In cancer patients, thrombolytics are often used to treat acute thromboembolic events like deep vein thrombosis (DVT) or pulmonary embolism (PE). The administration of thrombolytics in cancer patients needs to be carefully managed due to the increased risk of bleeding complications. Oncologists and cardiologists typically work together to determine the most appropriate treatment plan.
